MYUNGMOON Pharm co.,Ltd (017180.KS) KSC

1,810.00

+6(+0.33%)

Updated at January 14 03:30PM

Currency In KRW

Valuation

Market Cap60.91B
Enterprise Value144.02B
P/E Ratio40.03
PEG Ratio2.08
Price/Sales Ratio0.31
Price/Book Ratio0.6
Enterprise/Revenue0.78
Enterprise/EBITDA4.45

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.01
Operating Margin0.04

Management Effectiveness

Return On Assets0.01
Return On Equity0.02

Income Statement

Revenue186.44B
Revenue/Share5,996.49
Gross Profit104.97B
EBITDA5.67B
Net Income-3.03B
Diluted EPS-90.62

Balance Sheet

Total Cash6.7B
Total Cash/Share207.4
Total Debt96.23B
Total Debt/Equity0.98
Current Ratio0.97
Book Value Per Share3,210.23

Price History

52-Week Change-1.74
52-Week High2,055
52-Week Low1,412
Moving Average 50 Days1,766.02
Moving Average 200 Days1,689.38

Statistics

Average Volume120,984
Shares Outstanding33.43M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor513:500
Last Split DateMay 14, 2020